# T Cell Lymphoma -Stratified Therapy After Response to First-line Treatment-CR

> **NCT07353840** · — · RECRUITING · sponsor: **Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 160 (estimated)

## Conditions studied

- Peripheral T Cell Lymphoma

## Interventions

- **PROCEDURE:** Autologous Hematopoietic Stem Cell Transplantation
- **OTHER:** Observation

## Key facts

- **NCT ID:** NCT07353840
- **Lead sponsor:** Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-20
- **Primary completion:** 2029-05-30
- **Final completion:** 2029-09-30
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07353840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07353840, "T Cell Lymphoma -Stratified Therapy After Response to First-line Treatment-CR". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07353840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*